Principal Investigator
Pascal JOLY, Pr
University Hospital, Rouen
Total Trials
2
As PI
2
Completed
0
h-index
N/A
Publications
0
Years Active
2
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 32
Trial Status
Recruiting1
Other1
Role Distribution
Principal Investigator2
PI Rate100%
Activity Timeline
Clinical Trials (2)
Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis
Recurrent Aphtous Stomatitis
PrincipalinvestigatorStart date: 2022-04-10
Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid
Severe Forms of Mucous Membrane Pemphigoid
PrincipalinvestigatorStart date: 2019-07-11
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
University Hospital, Rouen
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Similar investigators will appear here based on research areas and collaboration patterns.
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis
Recurrent Aphtous Stomatitis
Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid
Severe Forms of Mucous Membrane Pemphigoid
All 2 trials loaded